NOVT vs BMI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

NOVT

51.4
AI Score
VS
NOVT Wins

BMI

35.6
AI Score

Investment Advisor Scores

NOVT

51score
Recommendation
HOLD

BMI

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric NOVT BMI Winner
Forward P/E 8.3893 31.348 NOVT
PEG Ratio 2.11 3.6635 NOVT
Revenue Growth 10.3% 0.1% NOVT
Earnings Growth 150.0% 4.2% NOVT
Tradestie Score 51.4/100 35.6/100 NOVT
Profit Margin 6.0% 14.4% BMI
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY NOVT

Relative Price Performance (Last 90 Days)

NOVT 1M: -14.3% · 3M: -25.4% BMI 1M: +19.3% · 3M: +20.0%

Current Technical Phase

NOVT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.9%), weak momentum, RSI 39

RSI (14): 38.8 · Price: $124.76

BMI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.2% over 20 days), RSI 60

RSI (14): 60.4 · Price: $156.55

Fundamentals Snapshot

Metric NOVT BMI
Market Cap — —
Forward P/E 28.3 31.6
Trailing P/E 92.4 36.8
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.4% 0.4%
Operating Margin 0.0% 0.2%
EPS 1.58 4.33
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, NOVT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.